Frontiers in Cellular Neuroscience, 2022 · DOI: 10.3389/fncel.2022.872501 · Published: April 22, 2022
The adult mammalian central nervous system (CNS) generally lacks the ability to regenerate axons after injury, unlike the peripheral nervous system (PNS). However, recent evidence suggests that both CNS and PNS neurons can revert to an embryonic-like growth state, termed "redevelopment," which is permissive for axon regeneration. Interestingly, serotonin neurons in the raphe nuclei and norepinephrine neurons in the locus coeruleus exhibit a robust ability to regenerate their axons unaided, challenging the traditional view that CNS axons cannot regenerate without experimental intervention. This review explores the intrinsic and extrinsic factors that influence axon regeneration in the CNS, the role of redevelopment in promoting regeneration, and the unique regenerative capabilities of neuromodulatory neurons.
Targeting factors that promote neuronal redevelopment and/or reduce the inhibitory environment in the CNS may enhance axon regeneration after injury.
Investigating the unique regenerative capabilities of serotonin and norepinephrine neurons could reveal novel regenerative programs applicable to other CNS neurons.
Shifting the focus from simply overcoming inhibitory signals to actively promoting a regenerative state in CNS neurons may improve therapeutic outcomes.